Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01889342
Other study ID # SveJoh 1
Secondary ID
Status Completed
Phase N/A
First received June 26, 2013
Last updated March 7, 2016
Start date August 2013
Est. completion date December 2015

Study information

Verified date March 2016
Source Modum Bad
Contact n/a
Is FDA regulated No
Health authority Norway:National Committee for Medical and Health Research Ethics
Study type Interventional

Clinical Trial Summary

Comorbidity is normal in clinical practice. Metacognitive Therapy (MCT) is a transdiagnostic model and could therefore be well suited when it comes to treating patients with high rates of comorbidity. So far, no studies have examined MCT in comparison with the best documented and evidence based treatment, cognitive behavioral treatment(CBT), in a randomized controlled trial consisting of mixed anxiety disorder sample with high degree of comorbidity.

The main aim of this study is to 1) Evaluate the effectiveness of metacognitive therapy in a sample of mixed anxiety disorders as compared to a group receiving existing evidence-based single diagnosis CBT- treatment protocols 2) Investigate patterns and mechanisms of change in the two treatments.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- DSM IV diagnoses of SAD, PD/A or PTSD (CSR>4)

- Withdraw of all psychotropic medications before treatment

Exclusion Criteria:

- Psychosis

- Not willing to accept randomization

- Comorbid conditions are in immediate need of treatment

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Metacognitive therapy

Cognitive behavioral therapy


Locations

Country Name City State
Norway Modum Bad Vikersund Buskerud

Sponsors (1)

Lead Sponsor Collaborator
Modum Bad

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Anxiety Disorders Interview Schedule for DSM-IV-Lifetime Version The ADIS -IV is a semistructured diagnostic interview designed to establish reliable DSM-IV anxiety, mood, somatoform and substance disorders. Interviewers assign a 0-8 clinical severity rating (CSR), that indicate their judgement of the degree of distress. PRE/POST/1 year follow up No
Primary Beck Anxiety Inventory (BAI) PRE/POST/weekly and 1 year follow up No
Secondary The Symptom Checklist 90(SCL90; Derogatis et al., 1996) Pre/Post/1 year follow up No
Secondary The Patient Health Questionnaire depression module (PHQ 9; Spitzer et al., 1999) Pre/Post and 1 year follow up No
Secondary Metacognitions Questionnaire- 30 (MCQ-30; Wells & Cartwright-Hatton, 2003) Pre/Post/weekly and 1 year follow up No
Secondary Working Alliance Inventory (WAI; Horwath & Greenberg, 1989) Pre/Post/weekly and 1 year follow up No
Secondary Cognitive attentional syndrome 1 (CAS1; Wells, 2009) Pre/Post/weekly and 1 year follow up No
Secondary The Repetitive Thinking Questionnaire(RTQ; McEvoy et al., 2010) Pre/Post and 1 year follow up No
Secondary PTSD Symptom scale Self Report (PSSR; Foa et al., 1993) Pre/Post and 1 year follow up No
Secondary Social Phobia Inventory (SPIN; Connor et al., 2000) Pre/Post and 1 year follow up No
Secondary Mobility inventory (MI; Chambless, 1985) Pre/Post and 1 year follow up No
Secondary SF 36 Pre/Post and 1 year follow up No
Secondary The Penn State Worry Questionnaire (PSWQ; Meyer, Miller, Metzger & Borkovec, 1990) Pre/Post and 1 year follow up No
Secondary Youngs Schema Questionnaire YSQ -75 (Young, 1998) Pre/Post and 1 year follow up No
Secondary The Inventory of Interpersonal Problems (IIP 64 C; Horowitz et al., 1988) Pre/Post and 1 year follow up No
Secondary Dysfunctional emotion regulations scale (DERS; Graz & Roemer, 2004) Pre/Post/ and 1 year follow up No